ExodusPoint Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

ExodusPoint Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$324K	Buy
2024 Q2	–	Sell
2024 Q1	$172K	Buy
2023 Q4	–	Sell
2023 Q3	$331K	Buy
2023 Q2	$281K	Buy
2021 Q4	–	Sell
2021 Q3	$335K	Buy
2019 Q4	–	Sell
2019 Q3	$158K	Buy
2019 Q2	–	Sell
2019 Q1	$666K	Buy